These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28643375)

  • 1. Dried blood spot sampling of nilotinib in patients with chronic myeloid leukaemia: a comparison with venous blood sampling.
    Boons CCLM; Chahbouni A; Schimmel AM; Wilhelm AJ; den Hartog YM; Janssen JJWM; Hendrikse NH; Hugtenburg JG; Swart EL
    J Pharm Pharmacol; 2017 Oct; 69(10):1265-1274. PubMed ID: 28643375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a dried blood spot sampling method towards therapeutic monitoring of radotinib in the treatment of chronic myeloid leukaemia.
    Lee J; Jung SY; Choi MY; Park JS; Park SK; Lim SA; Cho KH; Oh SY; Ha J; Kim DW; Lee J
    J Clin Pharm Ther; 2020 Oct; 45(5):1006-1013. PubMed ID: 32022312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of and patients' perspective on nilotinib dried blood spot self-sampling.
    Boons CCLM; Timmers L; Janssen JJWM; Swart EL; Hugtenburg JG; Hendrikse NH
    Eur J Clin Pharmacol; 2019 Jun; 75(6):825-829. PubMed ID: 30729257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation of dried blood spot sampling in therapeutic drug monitoring of ciclosporin A in allogeneic stem cell transplant recipients: direct comparison between capillary and venous sampling.
    Wilhelm AJ; Klijn A; den Burger JC; Visser OJ; Veldkamp AI; Janssen JJ; Swart EL
    Ther Drug Monit; 2013 Feb; 35(1):92-5. PubMed ID: 23296096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous measurement of imatinib, nilotinib and dasatinib in dried blood spot by ultra high performance liquid chromatography tandem mass spectrometry.
    Kralj E; Trontelj J; Pajič T; Kristl A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():150-6. PubMed ID: 22857863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dried blood spot analysis for therapeutic drug monitoring of pazopanib.
    de Wit D; den Hartigh J; Gelderblom H; Qian Y; den Hollander M; Verheul H; Guchelaar HJ; van Erp NP
    J Clin Pharmacol; 2015 Dec; 55(12):1344-50. PubMed ID: 26032288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Simple Method for Simultaneously Measuring the Concentrations of BCR-ABL and Bruton Tyrosine Kinase Inhibitors in Dried Blood Spot (DBS): A Pilot Study to Obtain Candidate Conversion Equations for Predicting Plasma Concentration Based on DBS Concentration.
    Mukai Y; Yoshida T; Kondo T; Miura J; Inotsume N; Toda T
    Ther Drug Monit; 2022 Dec; 44(6):762-770. PubMed ID: 36372934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Antipsychotics: Drawbacks of Its Clinical Application.
    Kloosterboer SM; de Winter BCM; Bahmany S; Al-Hassany L; Dekker A; Dieleman GC; van Gelder T; Dierckx B; Koch BCP
    Ther Drug Monit; 2018 Jun; 40(3):344-350. PubMed ID: 29505492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volumetric absorptive microsampling and dried blood spot microsampling vs. conventional venous sampling for tacrolimus trough concentration monitoring.
    Veenhof H; Koster RA; Junier LAT; Berger SP; Bakker SJL; Touw DJ
    Clin Chem Lab Med; 2020 Sep; 58(10):1687-1695. PubMed ID: 32412437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical and clinical validation of an LC-MS/MS method for carbamazepine, lamotrigine and levetiracetam in dried blood spots.
    Besten-Bertholee DD; Wegner I; Touw DJ; Ter Horst PGJ
    Eur J Hosp Pharm; 2024 Aug; 31(5):450-454. PubMed ID: 36894298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DBS sampling in imatinib therapeutic drug monitoring: from method development to clinical application.
    Antunes MV; Raymundo S; Wagner SC; Mattevi VS; Vieira N; Leite R; Reginato F; Capra MZ; Fogliatto L; Linden R
    Bioanalysis; 2015; 7(16):2105-17. PubMed ID: 26327189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of dried blood spot sampling for pharmacokinetic research and therapeutic drug monitoring of anti-tuberculosis drugs in children.
    Martial LC; Kerkhoff J; Martinez N; Rodríguez M; Coronel R; Molinas G; Roman M; Gomez R; Aguirre S; Jongedijk E; Huisman J; Touw DJ; Pérez D; Chaparro G; Gonzalez F; Aarnoutse RE; Alffenaar JW; Magis-Escurra C
    Int J Antimicrob Agents; 2018 Jul; 52(1):109-113. PubMed ID: 29751121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of total and unbound imatinib and metabolite LC-MS/MS assay to understand individual responses in CML and GIST patients.
    Streit F; Binder L; Hafke A; Brandhorst G; Braulke F; Haase D; Armbrust T; Cameron S; Ramadori G; Oellerich M; Walson P
    Ther Drug Monit; 2011 Oct; 33(5):632-43. PubMed ID: 21912334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of a dried blood spot C-reactive protein method to identify disease flares in rheumatoid arthritis patients.
    D'Cruz LG; McEleney KG; Cochrane C; Tan KBC; Shukla P; Gardiner PV; Small D; Zhang SD; Gibson DS
    Sci Rep; 2020 Dec; 10(1):21089. PubMed ID: 33273485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of Dried Blood Spot Cards to Determine Apple Phenolic Metabolites in Human Blood and Plasma After an Acute Intake of Red-Fleshed Apple Snack.
    Yuste S; Macià A; Ludwig IA; Romero MP; Fernández-Castillejo S; Catalán Ú; Motilva MJ; Rubió L
    Mol Nutr Food Res; 2018 Dec; 62(23):e1800623. PubMed ID: 30328671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study protocol of the RAND-study: a multicenter, prospective cohort study investigating response and adherence to nilotinib treatment in chronic myeloid leukemia.
    Boons CC; Swart EL; Timmers L; van de Ven PM; Janssen JJ; Hugtenburg JG
    BMC Cancer; 2014 Apr; 14():247. PubMed ID: 24712728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children.
    Dilo A; Daali Y; Desmeules J; Chalandon Y; Uppugunduri CRS; Ansari M
    Ther Drug Monit; 2020 Feb; 42(1):111-117. PubMed ID: 31348116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dried Blood Spot Sampling for Tacrolimus and Mycophenolic Acid in Children: Analytical and Clinical Validation.
    Martial LC; Hoogtanders KEJ; Schreuder MF; Cornelissen EA; van der Heijden J; Joore MA; Van Maarseveen EM; Burger DM; Croes S; Brüggemann RJM; Aarnoutse RE
    Ther Drug Monit; 2017 Aug; 39(4):412-421. PubMed ID: 28700522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of proprotein convertase subtilisin/kexin type 9 and nilotinib plasma concentrations on nilotinib-induced hypercholesterolaemia in patients with chronic myeloid leukaemia.
    Abumiya M; Akamine Y; Sato S; Takahashi S; Yoshioka T; Kameoka Y; Takahashi N; Miura M
    J Clin Pharm Ther; 2021 Apr; 46(2):382-387. PubMed ID: 33108009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole.
    Martial LC; van den Hombergh E; Tump C; Halmingh O; Burger DM; van Maarseveen EM; Brüggemann RJ; Aarnoutse RE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():16-23. PubMed ID: 29747155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.